Cargando…
Research progress of fibroblast growth factor 23 in acute kidney injury
Fibroblast growth factor 23 (FGF23) is primarily produced in bones and mainly regulates calcium and phosphorus metabolism. The level of circulating FGF23 increases rapidly in the early stage of acute kidney injury (AKI). Recent studies have shown that FGF23 may serve as a biomarker for the diagnosis...
Autores principales: | Zhang, Lina, Qin, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234887/ https://www.ncbi.nlm.nih.gov/pubmed/36416954 http://dx.doi.org/10.1007/s00467-022-05791-z |
Ejemplares similares
-
Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients
por: de Oliveira Neves, Fernanda Macedo, et al.
Publicado: (2019) -
New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
por: Mace, Maria L., et al.
Publicado: (2020) -
Fibroblast Growth Factor 23 Expression Is Increased in Multiple Organs in Mice With Folic Acid-Induced Acute Kidney Injury
por: Egli-Spichtig, Daniela, et al.
Publicado: (2018) -
Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015) -
UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)